These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31829175)

  • 1. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
    Mayers M; Li TS; Queralt-Rosinach N; Su AI
    BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RepCOOL: computational drug repositioning via integrating heterogeneous biological networks.
    Fahimian G; Zahiri J; Arab SS; Sajedi RH
    J Transl Med; 2020 Oct; 18(1):375. PubMed ID: 33008415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning of herbal compounds via a machine-learning approach.
    Kim E; Choi AS; Nam H
    BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning.
    Yang K; Yang Y; Fan S; Xia J; Zheng Q; Dong X; Liu J; Liu Q; Lei L; Zhang Y; Li B; Gao Z; Zhang R; Liu B; Wang Z; Zhou X
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36562715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MD-Miner: a network-based approach for personalized drug repositioning.
    Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the prediction of pharmacogenes using text-derived drug-gene relationships.
    Garten Y; Tatonetti NP; Altman RB
    Pac Symp Biocomput; 2010; ():305-14. PubMed ID: 19908383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.
    Lotfi Shahreza M; Ghadiri N; Green JR
    Methods Mol Biol; 2019; 1903():291-316. PubMed ID: 30547450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Recent Developments and Progress in Computational Drug Repositioning.
    Shi W; Chen X; Deng L
    Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
    Chen H; Zhang Z; Zhang J
    BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.